Combining M17 and Trametinib: A New Hope for Triple-Negative Breast Cancer?
Have you ever heard of triple-negative breast cancer (TNBC)? It's a tricky type of cancer that doesn't respond well to typical treatments. Scientists are on the hunt for better options. Recently, they discovered that TNBC cells rely on two key pathways: the PI3K/AKT pathway and the MAPK pathway. The